Mxi1 isoforms are expressed in hematological cell lines and normal bone marrow

Area of Science:

• Molecular Biology
• Gene Regulation
• Cancer Biology

Background:

• Mxi1 and c-Myc are basic helix-loop-helix, leucine zipper (bHLHZIP) transcriptional factors that dimerize with Max.
• Both proteins bind the E-box DNA sequence, but Mxi1 suppresses transcription while c-Myc activates it.
• Hematopoietic cells express novel Mxi1 transcripts, including Mxi-D, Mxi-ND, and Mxi-NF.

Purpose of the Study:

• To investigate the function of novel Mxi1 transcripts, particularly Mxi-D, in hematopoietic cells.
• To determine if Mxi-D acts as a dominant-negative regulator of Mxi1 and c-Myc functions.
• To elucidate the role of Mxi-D in the c-Myc protein network.

Main Methods:

• Identification and characterization of novel Mxi1 transcripts using molecular biology techniques.
• GST-pull down assays to assess protein-protein interactions (Mxi-D with Max and mSin3).
• Electrophoretic mobility shift assays (EMSA) to evaluate DNA binding of Mxi-D/Max heterodimers to the E-box.
• Reporter gene assays to measure transcriptional activity.
• Colony formation assays in Rat1 fibroblast cells to assess Mxi-D's effect on c-Myc-stimulated growth.

Main Results:

• Mxi-D and full-length Mxi1 (Mxi-F) are the dominant Mxi1 isoforms in normal bone marrow and hematological cell lines.
• Mxi-D protein binds Max and mSin3 PHA2 regions.
• Mxi-D/Max heterodimers do not bind the E-box DNA sequence, unlike Mxi-F/Max heterodimers.
• Mxi-D suppresses transcription similarly to Mxi-F in reporter gene assays.
• Mxi-D is less effective than Mxi-F in suppressing c-Myc-stimulated clonal growth.

Conclusions:

• Mxi-D functions as a dominant-negative isoform of Mxi-F within the c-Myc protein network.
• Mxi-D's inability to bind DNA while still dimerizing with Max underlies its dominant-negative activity.
• Mxi-D plays a significant role in regulating hematopoietic cell growth and potentially in hematological malignancies.